NCT07808723 Georgia CEAL RESTORES Family Diabetes Study
| NCT ID | NCT07808723 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Morehouse School of Medicine |
| Condition | Weight Reduction |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-08-29 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-08-29 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine whether a family-based lifestyle intervention reduces the risk of type 2 diabetes (T2D) among parents and their children. The intervention will also evaluate how well the program supports healthy lifestyle behaviors and family engagement. The primary outcome of this study is weight loss in parents. Researchers will evaluate changes in participants' weight and lifestyle behaviors before the study compared to the end of the study (12 weeks post intervention) and 3 months after participation in the program.
Eligibility Criteria
Inclusion Criteria: Parent/guardian must identify as African American or Hispanic, be 18+ years residing in the same household as the child (i.e., biological or have legal guardianship for child), have prediabetes (HbA1c level 5.7-6.4%) or determined to be at risk using CDC's Pre-Diabetes Risk Test, be willing to commit to participation in a 12-week intervention study, have no plans to move over the next 9-months, and are ambulatory and able to participate in physical activity. Children must be between the ages of 12-17 years old and are ambulatory and able to participate in physical activity. Exclusion Criteria: Participants will be excluded from the research study if the participant has severe psychological disorders that may prevent/interfere with study participation, physical impairments that may prevent participation in moderate intensity physical activity, have previous diagnosis of diabetes, have a history of congestive heart failure, renal failure, or recent (\<12 months) cardiovascular events such as myocardial infarction (heart attack) or stroke, taking medications that may affect endpoint analyses, have co-morbid contraindications to physical activity or dietary changes, or if the participant is currently pregnant or planning to become pregnant in the next year.
Contact & Investigator
Rakale C Quarells, PhD
PRINCIPAL INVESTIGATOR
Morehouse School of Medicine
Frequently Asked Questions
Who can join the NCT07808723 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Weight Reduction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07808723 currently recruiting?
Yes, NCT07808723 is actively recruiting participants. Contact the research team at kbrantley@msm.edu for enrollment information.
Where is the NCT07808723 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT07808723 clinical trial?
NCT07808723 is sponsored by Morehouse School of Medicine. The principal investigator is Rakale C Quarells, PhD at Morehouse School of Medicine. The trial plans to enroll 120 participants.